Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
自体间充质干细胞治疗继发性进行性多发性硬化症：一项开放标签 2a 期概念验证研究
期刊:Lancet Neurology
影响因子:46.5
doi:10.1016/S1474-4422(11)70305-2
Peter Connick, Madhan Kolappan, Charles Crawley, Daniel J Webber, Rickie Patani, Andrew W Michell, Ming-Qing Du, Shi-Lu Luan, Daniel R Altmann, Alan J Thompson, Alastair Compston, Michael A Scott, David H Miller, Siddharthan Chandran
